Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 91

1.

Incidence and risk factors of non-device-associated urinary tract infections in an acute-care hospital.

Strassle PD, Sickbert-Bennett EE, Klompas M, Lund JL, Stewart PW, Marx AH, DiBiase LM, Weber DJ.

Infect Control Hosp Epidemiol. 2019 Sep 2:1-6. doi: 10.1017/ice.2019.241. [Epub ahead of print]

PMID:
31475662
2.

Renin-Angiotensin-Aldosterone System-Based Antihypertensive Agents and the Risk of Colorectal Cancer Among Medicare Beneficiaries.

Htoo PT, Stürmer T, Jonsson-Funk M, Pate V, Simpson RJ Jr, Lund JL.

Epidemiology. 2019 Jul 23. doi: 10.1097/EDE.0000000000001065. [Epub ahead of print]

PMID:
31348009
3.

Geriatric oncology health services research: Cancer and Aging Research Group Infrastructure Core.

Wong ML, Lichtman SM, Morrow GR, Simmons J, Hargraves T, Gross CP, Lund JL, Lowenstein LM, Walter LC, McDermott CL, Mohile SG, Cohen HJ.

J Geriatr Oncol. 2019 Jul 17. pii: S1879-4068(19)30244-9. doi: 10.1016/j.jgo.2019.07.012. [Epub ahead of print] No abstract available.

PMID:
31326392
4.

Disparities in Mortality from Noncancer Causes among Adolescents and Young Adults with Cancer.

Anderson C, Lund JL, Weaver MA, Wood WA, Olshan AF, Nichols HB.

Cancer Epidemiol Biomarkers Prev. 2019 Sep;28(9):1417-1426. doi: 10.1158/1055-9965.EPI-18-1384. Epub 2019 Jun 17.

PMID:
31209147
5.

Study design choices for evaluating the comparative safety of diabetes medications: An evaluation of pioglitazone use and risk of bladder cancer in older US adults with type-2 diabetes.

Garry EM, Buse JB, Gokhale M, Lund JL, Nielsen ME, Pate V, Stürmer T.

Diabetes Obes Metab. 2019 Sep;21(9):2096-2106. doi: 10.1111/dom.13774. Epub 2019 Jun 17.

PMID:
31087620
6.

Health Care Utilization and Comorbidity History of North Carolina Medicaid Beneficiaries in a Controlled Substance "Lock-in" Program.

Naumann RB, Marshall SW, Lund JL, Skinner AC, Ringwalt C, Gottfredson NC.

N C Med J. 2019 May-Jun;80(3):135-142. doi: 10.18043/ncm.80.3.135.

7.

Propensity score methods to control for confounding in observational cohort studies: a statistical primer and application to endoscopy research.

Yang JY, Webster-Clark M, Lund JL, Sandler RS, Dellon ES, Stürmer T.

Gastrointest Endosc. 2019 Sep;90(3):360-369. doi: 10.1016/j.gie.2019.04.236. Epub 2019 Apr 30. Review.

PMID:
31051156
8.

Beliefs About Advanced Cancer Curability in Older Patients, Their Caregivers, and Oncologists.

Loh KP, Mohile SG, Lund JL, Epstein R, Lei L, Culakova E, McHugh C, Wells M, Gilmore N, Mohamed MR, Kamen C, Aarne V, Conlin A, Bearden J 3rd, Onitilo A, Wittink M, Dale W, Hurria A, Duberstein P.

Oncologist. 2019 Jun;24(6):e292-e302. doi: 10.1634/theoncologist.2018-0890. Epub 2019 Apr 23.

PMID:
31015317
9.

Author's Reply to: "Design flaws in statins and pancreatic cancer research" (IJC-19-0941).

Kirkegård J, Lund JL, Mortensen FV, Cronin-Fenton D.

Int J Cancer. 2019 Sep 1;145(5):1450-1451. doi: 10.1002/ijc.32349. Epub 2019 May 12. No abstract available.

PMID:
30994188
10.

Evidence of heterogeneity in statin-associated type 2 diabetes mellitus risk: A meta-analysis of randomized controlled trials and observational studies.

Engeda JC, Stackhouse A, White M, Rosamond WD, Lhachimi SK, Lund JL, Keyserling TC, Avery CL.

Diabetes Res Clin Pract. 2019 May;151:96-105. doi: 10.1016/j.diabres.2019.04.005. Epub 2019 Apr 4.

PMID:
30954511
11.

Restriction of Pharmacoepidemiologic Cohorts to Initiators of Medications in Unrelated Preventive Drug Classes to Reduce Confounding by Frailty in Older Adults.

Zhang HT, McGrath LJ, Ellis AR, Wyss R, Lund JL, Stürmer T.

Am J Epidemiol. 2019 Jul 1;188(7):1371-1382. doi: 10.1093/aje/kwz083.

PMID:
30927359
12.

Noncancer mortality among adolescents and young adults with cancer.

Anderson C, Lund JL, Weaver MA, Wood WA, Olshan AF, Nichols HB.

Cancer. 2019 Jun 15;125(12):2107-2114. doi: 10.1002/cncr.32063. Epub 2019 Mar 20.

PMID:
30892701
13.

Development and validation of a 5-year mortality prediction model using regularized regression and Medicare data.

Lund JL, Kuo TM, Brookhart MA, Meyer AM, Dalton AF, Kistler CE, Wheeler SB, Lewis CL.

Pharmacoepidemiol Drug Saf. 2019 May;28(5):584-592. doi: 10.1002/pds.4769. Epub 2019 Mar 19.

PMID:
30891850
14.

Geriatric Assessment Predicts Hospitalization Frequency and Long-Term Care Use in Older Adult Cancer Survivors.

Williams GR, Dunham L, Chang Y, Deal AM, Pergolotti M, Lund JL, Guerard E, Kenzik K, Muss HB, Sanoff HK.

J Oncol Pract. 2019 May;15(5):e399-e409. doi: 10.1200/JOP.18.00368. Epub 2019 Mar 14.

PMID:
30870086
15.

Statins and pancreatic cancer risk in patients with chronic pancreatitis: A Danish nationwide population-based cohort study.

Kirkegård J, Lund JL, Mortensen FV, Cronin-Fenton D.

Int J Cancer. 2019 Mar 12. doi: 10.1002/ijc.32264. [Epub ahead of print]

PMID:
30861115
16.

Comparison of Medicare Claims-based Proxy Measures of Poor Function and Associations With Treatment Receipt and Mortality in Older Colon Cancer Patients.

Mayer SE, Tan HJ, Peacock Hinton S, Sanoff HK, Stürmer T, Hester LL, Faurot KR, Jonsson Funk M, Lund JL.

Med Care. 2019 Apr;57(4):286-294. doi: 10.1097/MLR.0000000000001073.

PMID:
30789540
17.

Burden and Cost of Outpatient Hemorrhoids in the United States Employer-Insured Population, 2014.

Yang JY, Peery AF, Lund JL, Pate V, Sandler RS.

Am J Gastroenterol. 2019 May;114(5):798-803. doi: 10.14309/ajg.0000000000000143.

PMID:
30741736
18.

Preadmission use of antidepressants and risk of complications and death after colorectal cancer surgery: a nationwide population-based cohort study.

Lycke KD, Christiansen CF, Lund JL, Iversen LH, Nørgaard M.

Colorectal Dis. 2019 Jun;21(6):651-662. doi: 10.1111/codi.14579. Epub 2019 Mar 6.

PMID:
30740875
19.

Evaluating the Strength of the Association Between Industry Payments and Prescribing Practices in Oncology.

Mitchell AP, Winn AN, Lund JL, Dusetzina SB.

Oncologist. 2019 May;24(5):632-639. doi: 10.1634/theoncologist.2018-0423. Epub 2019 Feb 6.

PMID:
30728276
20.

Pharmacoepidemiology and Drug Safety's special issue on validation studies.

Chun DS, Lund JL, Stürmer T.

Pharmacoepidemiol Drug Saf. 2019 Feb;28(2):123-125. doi: 10.1002/pds.4694. Epub 2019 Feb 3. No abstract available.

PMID:
30714240
21.

The importance and implications of comparator selection in pharmacoepidemiologic research.

D'Arcy M, Stürmer T, Lund JL.

Curr Epidemiol Rep. 2018 Sep;5(3):272-283. doi: 10.1007/s40471-018-0155-y. Epub 2018 Jul 6.

22.

Cause-specific mortality among Medicare beneficiaries with newly diagnosed non-Hodgkin lymphoma subtypes.

Hester LL, Park SI, Wood WA, Stürmer T, Brookhart MA, Lund JL.

Cancer. 2019 Apr 1;125(7):1101-1112. doi: 10.1002/cncr.31821. Epub 2018 Dec 11.

PMID:
30548238
23.

Trends in Incidence of ACL Reconstruction and Concomitant Procedures Among Commercially Insured Individuals in the United States, 2002-2014.

Herzog MM, Marshall SW, Lund JL, Pate V, Mack CD, Spang JT.

Sports Health. 2018 Nov/Dec;10(6):523-531. doi: 10.1177/1941738118803616.

PMID:
30355175
24.

Burden and Cost of Gastrointestinal, Liver, and Pancreatic Diseases in the United States: Update 2018.

Peery AF, Crockett SD, Murphy CC, Lund JL, Dellon ES, Williams JL, Jensen ET, Shaheen NJ, Barritt AS, Lieber SR, Kochar B, Barnes EL, Fan YC, Pate V, Galanko J, Baron TH, Sandler RS.

Gastroenterology. 2019 Jan;156(1):254-272.e11. doi: 10.1053/j.gastro.2018.08.063. Epub 2018 Oct 10. Review. Erratum in: Gastroenterology. 2019 May;156(6):1936.

PMID:
30315778
25.

Diagnostic Assessment of Assumptions for External Validity: An Example Using Data in Metastatic Colorectal Cancer.

Webster-Clark MA, Sanoff HK, Stürmer T, Peacock Hinton S, Lund JL.

Epidemiology. 2019 Jan;30(1):103-111. doi: 10.1097/EDE.0000000000000926.

PMID:
30252687
26.

Impact of 5α-reductase inhibitor and α-blocker therapy for benign prostatic hyperplasia on prostate cancer incidence and mortality.

Van Rompay MI, Curtis Nickel J, Ranganathan G, Kantoff PW, Solomon KR, Lund JL, McKinlay JB.

BJU Int. 2019 Mar;123(3):511-518. doi: 10.1111/bju.14534. Epub 2018 Oct 24.

PMID:
30216624
27.

Inflammatory markers and overall survival in older adults with cancer.

Nishijima TF, Deal AM, Lund JL, Nyrop KA, Muss HB, Sanoff HK.

J Geriatr Oncol. 2019 Mar;10(2):279-284. doi: 10.1016/j.jgo.2018.08.004. Epub 2018 Aug 18.

PMID:
30131235
28.

Body mass index, calcium supplementation and risk of colorectal adenomas.

Barry EL, Lund JL, Westreich D, Mott LA, Ahnen DJ, Beck GJ, Bostick RM, Bresalier RS, Burke CA, Church TR, Rees JR, Robertson DJ, Baron JA.

Int J Cancer. 2019 Feb 1;144(3):448-458. doi: 10.1002/ijc.31803. Epub 2018 Oct 30.

PMID:
30117164
29.

Opioid tolerance and clinically recognized opioid poisoning among patients prescribed extended-release long-acting opioids.

Young JC, Lund JL, Dasgupta N, Jonsson Funk M.

Pharmacoepidemiol Drug Saf. 2019 Jan;28(1):39-47. doi: 10.1002/pds.4572. Epub 2018 Jun 11.

PMID:
29888409
30.

Real-World Evidence: What It Is and What It Can Tell Us According to the International Society for Pharmacoepidemiology (ISPE) Comparative Effectiveness Research (CER) Special Interest Group (SIG).

Yuan H, Ali MS, Brouwer ES, Girman CJ, Guo JJ, Lund JL, Patorno E, Slaughter JL, Wen X, Bennett D; ISPE Comparative Effectiveness Research Special Interest Group.

Clin Pharmacol Ther. 2018 Aug;104(2):239-241. doi: 10.1002/cpt.1086. Epub 2018 May 7.

PMID:
29733448
31.

Trajectories of dispensed prescription opioids among beneficiaries enrolled in a Medicaid controlled substance "lock-in" program.

Naumann RB, Marshall SW, Gottfredson NC, Lund JL, Ringwalt CL, Skinner AC.

Pharmacoepidemiol Drug Saf. 2019 Jan;28(1):16-24. doi: 10.1002/pds.4445. Epub 2018 Apr 26.

PMID:
29700904
32.

Frequency of Care and Mortality Following an Incident Diagnosis of Peripheral Artery Disease in the Inpatient or Outpatient Setting: The ARIC (Atherosclerosis Risk in Communities) Study.

Kalbaugh CA, Loehr L, Wruck L, Lund JL, Matsushita K, Bengtson LGS, Heiss G, Kucharska-Newton A.

J Am Heart Assoc. 2018 Apr 13;7(8). pii: e007332. doi: 10.1161/JAHA.117.007332.

33.

Controlling for Frailty in Pharmacoepidemiologic Studies of Older Adults: Validation of an Existing Medicare Claims-based Algorithm.

Cuthbertson CC, Kucharska-Newton A, Faurot KR, Stürmer T, Jonsson Funk M, Palta P, Windham BG, Thai S, Lund JL.

Epidemiology. 2018 Jul;29(4):556-561. doi: 10.1097/EDE.0000000000000833.

34.

Lower Cancer Incidence-Warfarin Effect or Immortal Time Bias?

Li X, Lund JL, Toh S.

JAMA Intern Med. 2018 Apr 1;178(4):584-585. doi: 10.1001/jamainternmed.2018.0367. No abstract available.

PMID:
29610881
35.

Frailty and Comorbidities Among Survivors of Adolescent and Young Adult Cancer: A Cross-Sectional Examination of a Hospital-Based Survivorship Cohort.

Smitherman AB, Anderson C, Lund JL, Bensen JT, Rosenstein DL, Nichols HB.

J Adolesc Young Adult Oncol. 2018 Jun;7(3):374-383. doi: 10.1089/jayao.2017.0103. Epub 2018 Mar 23.

36.

The incremental value of a geriatric assessment-derived three-item scale on estimating overall survival in older adults with cancer.

Nishijima TF, Deal AM, Lund JL, Nyrop KA, Muss HB, Sanoff HK.

J Geriatr Oncol. 2018 Jul;9(4):329-336. doi: 10.1016/j.jgo.2018.01.007. Epub 2018 Feb 13.

PMID:
29426572
37.

Patient-Reported Comorbidity and Survival in Older Adults with Cancer.

Williams GR, Deal AM, Lund JL, Chang Y, Muss HB, Pergolotti M, Guerard EJ, Shachar SS, Wang Y, Kenzik K, Sanoff HK.

Oncologist. 2018 Apr;23(4):433-439. doi: 10.1634/theoncologist.2017-0404. Epub 2017 Dec 14.

38.

Conditioning on future exposure to define study cohorts can induce bias: the case of low-dose acetylsalicylic acid and risk of major bleeding.

Lund JL, Horváth-Puhó E, Komjáthiné Szépligeti S, Sørensen HT, Pedersen L, Ehrenstein V, Stürmer T.

Clin Epidemiol. 2017 Nov 23;9:611-626. doi: 10.2147/CLEP.S147175. eCollection 2017.

39.

Evaluating short- and long-term impacts of a Medicaid "lock-in" program on opioid and benzodiazepine prescriptions dispensed to beneficiaries.

Naumann RB, Marshall SW, Lund JL, Gottfredson NC, Ringwalt CL, Skinner AC.

Drug Alcohol Depend. 2018 Jan 1;182:112-119. doi: 10.1016/j.drugalcdep.2017.10.001. Epub 2017 Nov 14.

PMID:
29150151
40.

No Increase in Risk of Acute Myocardial Infarction in Privately Insured Adults Prescribed Proton Pump Inhibitors vs Histamine-2 Receptor Antagonists (2002-2014).

Landi SN, Sandler RS, Pate V, Lund JL.

Gastroenterology. 2018 Mar;154(4):861-873.e6. doi: 10.1053/j.gastro.2017.10.042. Epub 2017 Nov 6.

PMID:
29122546
41.

RE: Colorectal Cancer Incidence Patterns in the United States, 1974-2013.

Murphy CC, Sanoff HK, Stitzenberg KB, Baron JA, Sandler RS, Yang YC, Lund JL.

J Natl Cancer Inst. 2017 Aug 1;109(8). doi: 10.1093/jnci/djx104. No abstract available.

42.

Impact of Allogeneic Stem Cell Transplantation in First Complete Remission in Acute Myeloid Leukemia: A National Population-Based Cohort Study.

Østgård LSG, Lund JL, Nørgaard JM, Nørgaard M, Medeiros BC, Nielsen B, Nielsen OJ, Overgaard UM, Kallenbach M, Marcher CW, Riis AH, Sengeløv H.

Biol Blood Marrow Transplant. 2018 Feb;24(2):314-323. doi: 10.1016/j.bbmt.2017.10.019. Epub 2017 Oct 16.

43.

Potential Medication-Related Problems in Older Breast, Colon, and Lung Cancer Patients in the United States.

Lund JL, Sanoff HK, Peacock Hinton S, Muss HB, Pate V, Stürmer T.

Cancer Epidemiol Biomarkers Prev. 2018 Jan;27(1):41-49. doi: 10.1158/1055-9965.EPI-17-0523. Epub 2017 Oct 4.

44.

Evaluating the Effectiveness of Neoadjuvant Chemotherapy in Reducing Mastectomy for Women With Breast Cancer.

Mohiuddin JJ, Deal AM, Lund JL, Carey LA, Baker BR, Zagar TM, Jones EL, Marks LB, Chen RC.

JNCI Cancer Spectr. 2017 Sep 23;1(1):pkx004. doi: 10.1093/jncics/pkx004. eCollection 2017 Sep.

45.

Biology and Etiology of Young-Onset Breast Cancers among Premenopausal African American Women: Results from the AMBER Consortium.

Chollet-Hinton L, Olshan AF, Nichols HB, Anders CK, Lund JL, Allott EH, Bethea TN, Hong CC, Cohen SM, Khoury T, Zirpoli GR, Borges VF, Rosenberg LA, Bandera EV, Ambrosone CB, Palmer JR, Troester MA.

Cancer Epidemiol Biomarkers Prev. 2017 Dec;26(12):1722-1729. doi: 10.1158/1055-9965.EPI-17-0450. Epub 2017 Sep 13.

46.

A novel D2O tracer method to quantify RNA turnover as a biomarker of de novo ribosomal biogenesis, in vitro, in animal models, and in human skeletal muscle.

Brook MS, Wilkinson DJ, Mitchell WK, Lund JL, Phillips BE, Szewczyk NJ, Kainulainen H, Lensu S, Koch LG, Britton SL, Greenhaff PL, Smith K, Atherton PJ.

Am J Physiol Endocrinol Metab. 2017 Dec 1;313(6):E681-E689. doi: 10.1152/ajpendo.00157.2017. Epub 2017 Aug 15.

47.

Trends in Antibiotic Use by Birth Season and Birth Year.

Kinlaw AC, Stürmer T, Lund JL, Pedersen L, Kappelman MD, Daniels JL, Frøslev T, Mack CD, Sørensen HT.

Pediatrics. 2017 Sep;140(3). pii: e20170441. doi: 10.1542/peds.2017-0441. Epub 2017 Aug 14.

48.

Frailty Index Developed From a Cancer-Specific Geriatric Assessment and the Association With Mortality Among Older Adults With Cancer.

Guerard EJ, Deal AM, Chang Y, Williams GR, Nyrop KA, Pergolotti M, Muss HB, Sanoff HK, Lund JL.

J Natl Compr Canc Netw. 2017 Jul;15(7):894-902. doi: 10.6004/jnccn.2017.0122.

PMID:
28687577
49.

Comparative safety of pioglitazone versus clinically meaningful treatment alternatives concerning the risk of bladder cancer in older US adults with type 2 diabetes.

Garry EM, Buse JB, Lund JL, Pate V, Stürmer T.

Diabetes Obes Metab. 2018 Jan;20(1):129-140. doi: 10.1111/dom.13049. Epub 2017 Aug 8.

PMID:
28661561
50.

Incidence of Anterior Cruciate Ligament Reconstruction Among Adolescent Females in the United States, 2002 Through 2014.

Herzog MM, Marshall SW, Lund JL, Pate V, Mack CD, Spang JT.

JAMA Pediatr. 2017 Aug 1;171(8):808-810. doi: 10.1001/jamapediatrics.2017.0740. No abstract available.

Supplemental Content

Support Center